webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG8-acetic acid

  CAS No.: 868594-52-9   Cat No.: BADC-01175   Purity: >98.0% 4.5  

Fmoc-N-amido-PEG8-acetic acid acts as a protective group-containing ADC linker intermediate, enhancing conjugation flexibility and solubility in antibody-drug conjugates for precise drug delivery.

Fmoc-N-amido-PEG8-acetic acid

Structure of 868594-52-9

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C33H47NO12
Molecular Weight
649.73
Shipping
Room temperature
Shipping
Store at -20°C, keep in dry and avoid sunlight

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-NH-PEG8-CH2COOH; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azatriacontan-30-oic acid; Fmoc-PEG8-acetic acid; 26-[(9-Fluorenylmethoxycarbonyl)amino]-3,6,9,12,15,18,21,24-octaoxahexacosanoic acid; 5,8,11,14,17,20,23,26-Octaoxa-2-azaoctacosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester; Fmoc-NH-8(ethylene glycol)-acetic acid; 2,7,10,13,16,19,22,25,28-Nonaoxa-4-azatriacontan-30-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-
IUPAC Name
2-[2-[2-[2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCC(=O)O
InChI
InChI=1S/C33H47NO12/c35-32(36)26-45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-10-9-34-33(37)46-25-31-29-7-3-1-5-27(29)28-6-2-4-8-30(28)31/h1-8,31H,9-26H2,(H,34,37)(H,35,36)
InChIKey
JRLUSGRARXJCNA-UHFFFAOYSA-N
Density
1.201±0.06 g/cm3 (Predicted)
Solubility
Soluble in DMSO (10 mm)
PSA
149.47000
Appearance
Pale Yellow Oily Matter
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20°C, keep in dry and avoid sunlight
Boiling Point
773.7±60.0°C (Predicted)
Form
Solid

Fmoc-N-amido-PEG8-acetic acid, a versatile linker prevalent in peptide and protein chemistry, showcases a multitude of applications across various fields. Here are four key applications of this compound:

Peptide Synthesis: Positioned at the heart of solid-phase peptide synthesis (SPPS), Fmoc-N-amido-PEG8-acetic acid stands as a crucial instrument for constructing elaborate and extended peptides. The incorporation of a polyethylene glycol (PEG) spacer not only boosts solubility but also mitigates aggregation, streamlining the synthesis and purification processes. Researchers harness this linker to fabricate peptides tailored for drug development, molecular biology inquiries, and therapeutic endeavors.

Protein Conjugation: Acting as a cornerstone in protein conjugation, this compound facilitates the coupling of proteins with an array of biomolecules spanning from drugs to fluorophores to other peptides. Serving as a flexible and hydrophilic bridge, the linker preserves the biological functionality of proteins while enhancing their solubility and stability. This capability proves pivotal in fabricating bioconjugates for targeted drug delivery systems and diagnostic applications.

Drug Delivery Systems: Standing at the forefront of drug delivery innovation, Fmoc-N-amido-PEG8-acetic acid plays a pivotal role in crafting cutting-edge drug delivery platforms, including nanoparticle and liposome formulations. Through the process of PEGylation, the pharmacokinetic properties are bolstered while reducing the immunogenicity of delivery systems. By affixing this linker to therapeutic agents, researchers can precisely modulate drug release profiles, amplifying treatment efficacy and reinforcing patient adherence.

Surface Functionalization: Within the realm of surface chemistry, this linker emerges as a key protagonist in functionalizing biomaterial surfaces to augment biocompatibility and anti-fouling attributes. PEGylation of surfaces, such as implants or biosensors, diminishes protein adsorption and cell adhesion, thereby enhancing device functionality and durability. This advancement elevates the utility of biotechnological devices in medical and analytical settings, underscoring the significance of surface modification in optimizing device performance and longevity with intricate precision.

1. Atroposelective Synthesis of 1,1'-Bipyrroles Bearing a Chiral N-N Axis: Chiral Phosphoric Acid Catalysis with Lewis Acid Induced Enantiodivergence
Yaru Gao, Luo-Yu Wang, Tao Zhang, Bin-Miao Yang, Yu Zhao Angew Chem Int Ed Engl. 2022 Apr 11;61(16):e202200371. doi: 10.1002/anie.202200371. Epub 2022 Feb 24.
We present herein a highly efficient atroposelective synthesis of axially chiral 1,1'-bipyrroles bearing an N-N linkage from simple hydrazine and 1,4-diones. Further product derivatizations led to axially chiral bifunctional compounds with high potential in asymmetric catalysis. For this chrial phosphoric acid (CPA)-catalyzed double Paal-Knorr reaction, an intriguing Fe(OTf)3 -induced enantiodivergence was also observed.
2. Acidity characterization of heterogeneous catalysts by solid-state NMR spectroscopy using probe molecules
Anmin Zheng, Shang-Bin Liu, Feng Deng Solid State Nucl Magn Reson. 2013 Oct-Nov;55-56:12-27. doi: 10.1016/j.ssnmr.2013.09.001. Epub 2013 Sep 20.
Characterization of the surface acidic properties of solid acid catalysts is a key issue in heterogeneous catalysis. Important acid features of solid acids, such as their type (Brønsted vs. Lewis acid), distribution and accessibility (internal vs. external sites), concentration (amount), and strength of acid sites are crucial factors dictating their reactivity and selectivity. This short review provides information on different solid-state NMR techniques used for acidity characterization of solid acid catalysts. In particular, different approaches using probe molecules containing a specific nucleus of interest, such as pyridine-d5, 2-(13)C-acetone, trimethylphosphine, and trimethylphosphine oxide, are compared. Incorporation of valuable information (such as the adsorption structure, deprotonation energy, and NMR parameters) from density functional theory (DFT) calculations can yield explicit correlations between the chemical shift of adsorbed probe molecules and the intrinsic acid strength of solid acids. Methods that combine experimental NMR data with DFT calculations can therefore provide both qualitative and quantitative information on acid sites.
3. The Stephan Curve revisited
William H Bowen Odontology. 2013 Jan;101(1):2-8. doi: 10.1007/s10266-012-0092-z. Epub 2012 Dec 6.
The Stephan Curve has played a dominant role in caries research over the past several decades. What is so remarkable about the Stephan Curve is the plethora of interactions it illustrates and yet acid production remains the dominant focus. Using sophisticated technology, it is possible to measure pH changes in plaque; however, these observations may carry a false sense of accuracy. Recent observations have shown that there may be multiple pH values within the plaque matrix, thus emphasizing the importance of the milieu within which acid is formed. Although acid production is indeed the immediate proximate cause of tooth dissolution, the influence of alkali production within plaque has received relative scant attention. Excessive reliance on Stephan Curve leads to describing foods as "safe" if they do not lower the pH below the so-called "critical pH" at which point it is postulated enamel dissolves. Acid production is just one of many biological processes that occur within plaque when exposed to sugar. Exploration of methods to enhance alkali production could produce rich research dividends.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Pyrrolobenzodiazepine (PBD) | Mal-PEG4-VA-PBD | VA-PAB-PBD | MC-VC-PAB-Tubulysin M | N-SMP | Ald-PEG23-SPDP | Azide-C2-SS-C2-biotin | DBCO-acid | Fmoc-N-amido-PEG1-acetic acid | Fmoc-N-amido-PEG6-acetic acid | Fmoc-N-amido-PEG8-acetic acid
Send Inquiry
Verification code
Inquiry Basket